A 26-year-old female law student presents with an 8-week history of chronic cough and episodic chest tightness triggered by exercise, cold air, and strong perfumes. She has a history of childhood atopic dermatitis and allergic rhinitis. Her baseline spirometry is completely normal (FEV1 98% predicted, FEV1/FVC 0.81, negative bronchodilator reversibility). Methacholine challenge testing is performed using doubling doses of methacholine via nebulizer. Her FEV1 drops from 3.08 L at baseline to 2.60 L at 4 mg/mL, with PC20 calculated at 4.0 mg/mL as shown by the marker **A** in the diagram. Which of the following best describes the clinical significance of this result?
A. Fixed airway obstruction unresponsive to bronchodilators
B. Mild bronchial hyperresponsiveness supporting asthma diagnosis in appropriate clinical context
C. Moderate-to-severe bronchial hyperresponsiveness requiring immediate intubation
D. Normal airway responsiveness effectively ruling out asthma
Explanation
Why "Mild bronchial hyperresponsiveness supporting asthma diagnosis in appropriate clinical context" is right
According to ATS/ERS 2017 guidelines, a PC20 of 4.0 mg/mL falls within the 1–4 mg/mL range, which defines mild bronchial hyperresponsiveness. The marker A in the diagram represents PC20 <4 mg/mL (or PD20 <100 mcg), indicating significant bronchial hyperresponsiveness consistent with asthma. In this patient with suggestive symptoms (exercise-induced chest tightness, nocturnal cough, atopic history), normal baseline spirometry, and positive methacholine challenge, the diagnosis of asthma is supported. The pathophysiology reflects underlying airway inflammation, remodeling, and increased smooth muscle mass causing exaggerated bronchoconstriction in response to M3 muscarinic receptor stimulation by methacholine.
Why each distractor is wrong
Moderate-to-severe bronchial hyperresponsiveness requiring immediate intubation: PC20 <1 mg/mL defines moderate-to-severe hyperresponsiveness; this patient's PC20 is 4.0 mg/mL (mild). Asthma diagnosed on methacholine challenge does not automatically require intubation; management begins with inhaled corticosteroids and trigger avoidance per GINA 2024 guidelines.
Normal airway responsiveness effectively ruling out asthma: PC20 >16 mg/mL indicates normal airway responsiveness and a negative test. This patient's PC20 of 4.0 mg/mL is clearly abnormal and positive, not normal. A negative methacholine test has high negative predictive value (~95%) to rule out asthma, but a positive test supports the diagnosis in the appropriate clinical context.
Fixed airway obstruction unresponsive to bronchodilators: Fixed obstruction (marker C in the diagram) shows no FEV1 drop with methacholine and does not reverse with bronchodilators. This patient showed a 20% drop in FEV1 with methacholine and recovered FEV1 to 3.20 L within 15 minutes after 400 mcg salbutamol, confirming reversible airway obstruction, not fixed obstruction.
High-YieldNEET PG
PC20 1–4 mg/mL = mild hyperresponsiveness (asthma likely); PC20 <1 = moderate-to-severe; PC20 >16 = normal (asthma ruled out). Methacholine challenge is the gold standard for detecting airway hyperresponsiveness when baseline spirometry is normal.
ATS/ERS 2017 Technical Standard on Bronchial Challenge Testing; GINA 2024 Strategy Report; Harrison's Principles of Internal Medicine, 21st ed., Chapter 287: Asthma
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
